Physician profile
Chad E Allen
NPI 1780293266
$5,748.65
in general payments reported to CMS, 2019-2025
42 companies · $594 in 2025
The $594 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $468 · 2022: $823 · 2023: $2,390 · 2024: $1,474 · 2025: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,457.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,290.92 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $1,257.12 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $574.93 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $376.98 | 2021-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $339.94 | 2021-2025 | Mounjaro, Jardiance, Emgality |
| Astellas Pharma US INC | $226.89 | 2023-2025 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $208.88 | 2023-2024 | Jardiance |
| Dexcom, INC. | $127.31 | 2023-2024 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $114.48 | 2022-2025 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $97.00 | 2022 | |
| Ironwood Pharmaceuticals, INC | $95.00 | 2022-2024 | |
| Biohaven Pharmaceuticals, INC. | $86.24 | 2021 | |
| Sanofi-Aventis U.S. LLC | $82.02 | 2023 | |
| Lundbeck LLC | $81.24 | 2023-2024 | Vyepti |
| Amgen INC. | $58.87 | 2022-2025 | Krystexxa, Otezla, Repatha |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.